consult with drop.png

EMCREG-International leverages it’s international acute care experts to analyze key datasets, provide opinion on the practice of emergency medicine, thrombosis, acute cardiovascular emergencies, acute neurovascular emergencies and critical care, and debate key issues important to practice.

Our members are all well known academic clinician researchers and thought leaders. Representing 44 academic institutions, managing more than a million combined ED patients annually, our academic emergency physician educators provide unparalleled experience in acute care education, clinical care and research.

The wealth of experience and clinical acumen associated with such a geographically diverse network of veteran clinician researchers has resulted in the development of the consultation arm of EMCREG-International. These consultation efforts are geared toward helping companies understand both the clinical usefulness and obstacles associated with embracing a new diagnostic or treatment technology in the clinical ED setting. The drive to identify and assess new technologies is equally important to the clinicians making up the EMCREG network as it is to the manufacturers of diagnostic and therapeutic modalities. 

This ability to rapidly organize such an expert panel with minimal effort has proved appealing for companies facing short development timelines. Popular consultation topics include:

  1. Will a promising technology ultimately be practical in the clinical ED or acute setting in its current form?

  2. What are the practical, clinical and political obstacles to adopting promising new technologies?

  3. What alterations to a technology or its marketing would allow its utility and acceptance in the ED or acute care setting to be realized?

  4. Will a proposed research design be feasible in an emergency department setting?

  5. As the gatekeeper of many acute care patient presentations, how can enrollment in the ED be optimized in in acute care trials and cross specialty trial collaborations.

  6. Feasibility and adoption of new treatment options in the real world acute care practice

  7. Barriers to adoption of new biomedical and diagnostic devices in the real world acute care practice

  8. Barriers to adoption of new biomarkers and laboratory testing in the real world acute care practice

  9. Consensus panel recommendations and guideline development

  10. Managing barriers to clinical research in the acute care setting and facilitating inter-specialty collaboration.

Please feel free to contact our offices if the idea of a consultation roundtable or collaboration interests your organization.